Arcellx (ACLX) Short-term Investments (2021 - 2025)
Arcellx's (ACLX) quarterly Short-term Investments came in at $370.1 million in Q4 2025, down 23.17% year-on-year from $481.7 million in Q4 2024, and down 3.22% quarter-over-quarter from $382.4 million in Q3 2025.
Arcellx (ACLX) Short-term Investments (2021 - 2025) Analysis & Trends
Arcellx's Short-term Investments history runs 5 years deep, the most recent figure standing at $370.1 million for Q4 2025.
- On a quarterly basis, Short-term Investments fell 23.17% year-over-year to $370.1 million in Q4 2025; TTM through Dec 2025 was $370.1 million, a 23.17% decrease from a year earlier, with the FY2025 full-year figure at $370.1 million, down 23.17% from the prior year.
- Short-term Investments retreated to $370.1 million in Q4 2025 per ACLX's latest filing, from $382.4 million in the prior quarter.
- Across five years, Short-term Investments topped out at $481.7 million in Q4 2024 and bottomed at $208000.0 in Q1 2024.
- The 5-year median for Short-term Investments is $224.0 million (2022), against an average of $220.2 million.
- Across the five-year window, Short-term Investments sank 99.93% in 2024 and jumped 222209.62% in 2025, its largest moves.
- Year by year, Short-term Investments stood at $73.8 million in 2021, then surged by 203.61% to $224.0 million in 2022, then soared by 37.24% to $307.4 million in 2023, then soared by 56.68% to $481.7 million in 2024, then retreated by 23.17% to $370.1 million in 2025.
- Per Business Quant, the three latest ACLX Short-term Investments figures stand at $370.1 million (Q4 2025), $382.4 million (Q3 2025), and $462.4 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 370.07 Mn |
| Sep 30, 2025 | 382.38 Mn |
| Mar 31, 2025 | 462.40 Mn |
| Dec 31, 2024 | 481.70 Mn |
| Sep 30, 2024 | 208,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Mar 31, 2024 | 208,000.00 |
| Dec 31, 2023 | 307.43 Mn |
| Sep 30, 2023 | 313.60 Mn |
| Jun 30, 2023 | 202.82 Mn |
| Mar 31, 2023 | 258.70 Mn |
| Sep 30, 2022 | 224.02 Mn |
| Jun 30, 2022 | 142.45 Mn |
| Mar 31, 2022 | 83.77 Mn |
| Dec 31, 2021 | 73.78 Mn |